This webinar will discuss the current methods used to diagnose, treat, and prevent the different classes of allergic ocular surface diseases and their common associated complications.
• Differentiate between the multiple classes and types of ocular allergy
• Discuss the various treatment options available to manage each type of ocular allergy
• Apply useful methods for preventing ocular allergy and providing effective patient education
Dr. Amanda Furr
A Texas native from El Paso, Dr. Furr received her BBA in entrepreneurial management at Texas Christian University in Fort Worth. She graduated from Indiana University School of Optometry in 2013 and completed a residency in primary care and ocular disease at the Mt. Vernon VA Medical Center within the Veterans Healthcare System of the Ozarks.
Dr. Furr currently practices primary care optometry at First Eye Care in North Dallas after working at a tertiary care and research clinic, Eye Consultants of Texas, and Lonestar Ambulatory Surgery Center in Grapevine, Texas. She has participated in several FDA trials for corneal cross-linking and cataract surgery. She was named the national winner of the Alcon National Case Report award and is a published coauthor in a scientific journal, Optometric Education. Dr. Furr specializes in medical management of ocular surface diseases and glaucoma, pre-operative consultations for cataract and refractive surgery, and postoperative co-management.
Dr. Furr is licensed by the Texas Optometry Board and the National Board of Examiners in Optometry. She is a member of the Texas Optometric Association and the American Academy of Optometry. She currently lives in Dallas, TX and enjoys cheering on TCU football/IU basketball and attending Dallas Mavericks games.
AAAPC CME Webinar 2
AAAPC Sept 2017 Webinar Recording with Dr. Amanda Furr
The Academy of Allergy and Asthma in Primary Care (AAAPC) is a national non-profit organization, which supports innovative care models for allergy and asthma care in the primary care setting. AAAPC assists physicians in expanding their role to provide high quality allergy care and therapy to the underserved patient population.